FDA Requires GLP-1 Drugmakers to Warn of Rare Eye Condition That Can Cause Vision Loss
The FDA is requiring GLP-1 drugmakers to update labels with a warning about a rare eye condition that may cause permanent vision loss.
Covered by the press in 2 countries
Among the outlets we follow
- United States2
- France1
